BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 19097929)

  • 1. The role of KLF6 and its splice variants in cancer therapy.
    DiFeo A; Martignetti JA; Narla G
    Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
    Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
    Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.
    Andreoli V; Gehrau RC; Bocco JL
    IUBMB Life; 2010 Dec; 62(12):896-905. PubMed ID: 21154818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
    Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
    Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.
    DiFeo A; Narla G; Hirshfeld J; Camacho-Vanegas O; Narla J; Rose SL; Kalir T; Yao S; Levine A; Birrer MJ; Bonome T; Friedman SL; Buller RE; Martignetti JA
    Clin Cancer Res; 2006 Jun; 12(12):3730-9. PubMed ID: 16778100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor.
    DiFeo A; Narla G; Camacho-Vanegas O; Nishio H; Rose SL; Buller RE; Friedman SL; Walsh MJ; Martignetti JA
    Oncogene; 2006 Sep; 25(44):6026-31. PubMed ID: 16702959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
    Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
    Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of the klf6 tumor suppressor gene upon cell damaging treatments in cancer cells.
    Gehrau RC; D'Astolfo DS; Andreoli V; Bocco JL; Koritschoner NP
    Mutat Res; 2011 Feb; 707(1-2):15-23. PubMed ID: 21147133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KLF6: mutational analysis and effect on cancer cell proliferation.
    Yin D; Komatsu N; Miller CW; Chumakov AM; Marschesky A; McKenna R; Black KL; Koeffler HP
    Int J Oncol; 2007 Jan; 30(1):65-72. PubMed ID: 17143513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations of the KLF6 gene in gastric cancer.
    Cho YG; Kim CJ; Park CH; Yang YM; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
    Oncogene; 2005 Jun; 24(28):4588-90. PubMed ID: 15824733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.
    Narla G; Difeo A; Reeves HL; Schaid DJ; Hirshfeld J; Hod E; Katz A; Isaacs WB; Hebbring S; Komiya A; McDonnell SK; Wiley KE; Jacobsen SJ; Isaacs SD; Walsh PC; Zheng SL; Chang BL; Friedrichsen DM; Stanford JL; Ostrander EA; Chinnaiyan AM; Rubin MA; Xu J; Thibodeau SN; Friedman SL; Martignetti JA
    Cancer Res; 2005 Feb; 65(4):1213-22. PubMed ID: 15735005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLF6 degradation after apoptotic DNA damage.
    Banck MS; Beaven SW; Narla G; Walsh MJ; Friedman SL; Beutler AS
    FEBS Lett; 2006 Dec; 580(30):6981-6. PubMed ID: 17113081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
    Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
    Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.
    Camacho-Vanegas O; Narla G; Teixeira MS; DiFeo A; Misra A; Singh G; Chan AM; Friedman SL; Feuerstein BG; Martignetti JA
    Int J Cancer; 2007 Sep; 121(6):1390-5. PubMed ID: 17514651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function.
    Slavin DA; Koritschoner NP; Prieto CC; López-Díaz FJ; Chatton B; Bocco JL
    Oncogene; 2004 Oct; 23(50):8196-205. PubMed ID: 15378003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLF6, a candidate tumor suppressor gene mutated in prostate cancer.
    Narla G; Heath KE; Reeves HL; Li D; Giono LE; Kimmelman AC; Glucksman MJ; Narla J; Eng FJ; Chan AM; Ferrari AC; Martignetti JA; Friedman SL
    Science; 2001 Dec; 294(5551):2563-6. PubMed ID: 11752579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma.
    Song J; Kim CJ; Cho YG; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1286-9. PubMed ID: 16872311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility.
    Solé X; Hernández P; de Heredia ML; Armengol L; Rodríguez-Santiago B; Gómez L; Maxwell CA; Aguiló F; Condom E; Abril J; Pérez-Jurado L; Estivill X; Nunes V; Capellá G; Gruber SB; Moreno V; Pujana MA
    BMC Genomics; 2008 Jan; 9():12. PubMed ID: 18190704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
    Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
    J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.